These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14050317)

  • 21. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS].
    SANTOSTORIBIO F
    Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889
    [No Abstract]   [Full Text] [Related]  

  • 22. [FIBRINOLYTIC TREATMENT. ITS INDICATIONS, ITS CONTROL, ITS RESULTS].
    SALMON J; LAMBERT PH; DELVIGNE J
    Acta Cardiol; 1963; 18():254-72. PubMed ID: 14045890
    [No Abstract]   [Full Text] [Related]  

  • 23. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 24. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 25. EFFECTS OF FIBRINOLYTIC AGENTS ON EXPERIMENTAL AND CLINICAL THROMBOSIS.
    TSAPOGAS MJ
    J Clin Pathol; 1964 May; 17(3):360-1. PubMed ID: 14159483
    [No Abstract]   [Full Text] [Related]  

  • 26. [LIMITATIONS OF USE AND HAZARDS OF FIBRINOLYTIC THERAPY WITH STREPTOKINASE].
    OHLER WG
    Med Klin; 1964 Jan; 59():61-4. PubMed ID: 14134684
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the dosage of streptokinase in fibrinolytic therapy].
    STACHER A; BOEHNEL J
    Wien Klin Wochenschr; 1961 Sep; 73():665-8. PubMed ID: 13916043
    [No Abstract]   [Full Text] [Related]  

  • 28. [A contribution to fibrinolytic therapy with streptokinase and streptolysin].
    FISCHBACHER W
    Thromb Diath Haemorrh; 1961 Dec; 6():547-72. PubMed ID: 13893097
    [No Abstract]   [Full Text] [Related]  

  • 29. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM.
    OLOW B
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706
    [No Abstract]   [Full Text] [Related]  

  • 30. [DRUGS ACTIVATING FIBRINOLYSIS. THERAPEUTIC USES].
    CAMPANI M
    Minerva Chir; 1963 Dec; 18():1118-27. PubMed ID: 14118238
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the effect of urokinase on the fibrinolytic activity of the blood].
    ANDREENKO GV; STRUKOVA SM
    Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411
    [No Abstract]   [Full Text] [Related]  

  • 32. [1st experiences with highly purified streptokinase in thrombolysis in surgery].
    MUELLER K
    Bruns Beitr Klin Chir; 1961 May; 202():340-9. PubMed ID: 13773527
    [No Abstract]   [Full Text] [Related]  

  • 33. [TRYPSIN-CHYMOTRYPSIN IN THE VASCULAR OCCLUSIVE PROCESSES].
    MOSSO HE; PERGOLA F; MARCEILLAC E
    Prensa Med Argent; 1963 Apr; 50():1081-4. PubMed ID: 14089189
    [No Abstract]   [Full Text] [Related]  

  • 34. FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
    AMERY A; VERMYLEN J; MAES H; VERSTRAETE V
    Sangre (Barc); 1964; 61():9-11. PubMed ID: 14214896
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY].
    KAPPERT A
    Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260
    [No Abstract]   [Full Text] [Related]  

  • 36. [THE STATUS OF THE BLOOD FIBRINOLYTIC ACTIVITY IN HEMOPHILIA PATIENTS].
    EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM; EFENDIEV ZI
    Klin Med (Mosk); 1963 Jan; 41():122-5. PubMed ID: 14121310
    [No Abstract]   [Full Text] [Related]  

  • 37. THE EFFECT OF COPPER IONS ON CLOT LYSIS TIME IN THE FIBRINOLYTIC ASSAY OF STREPTOKINASE.
    BOGERT AB
    Thromb Diath Haemorrh; 1965 Jun; 13():477-83. PubMed ID: 14347869
    [No Abstract]   [Full Text] [Related]  

  • 38. [FIBRINOLYTIC PROPERTIES OF THE CONTACT FACTOR].
    AZNAR J
    Rev Esp Fisiol; 1964 Jun; 20():43-51. PubMed ID: 14185256
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relation between the fibrinolytic activity of the blood and aseptic wound healing disorders in animal experiments].
    BENZER H; BLUEMEL G; PIZA F
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963; 302():463-71. PubMed ID: 13967580
    [No Abstract]   [Full Text] [Related]  

  • 40. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.